For example, in pre-clinical models of frontotemporal dementia,12 subarachnoid haemorrhage,13 and prion disease,14 treatment with the potent and selective PERK inhibitor, GSK2606414,15 demonstrated neuroprotective effects. Here, EIF2AK3 is linked to frontotemporal dementia.